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SUMMARY
Failure to make adaptive immune responses is a hall-
mark of aging. Reduced B cell function leads to poor
vaccination efficacy and a high prevalence of infec-
tions in the elderly. Here we show that reduced auto-
phagy is a central molecular mechanism underlying
immune senescence. Autophagy levels are specif-
ically reduced in mature lymphocytes, leading to
compromised memory B cell responses in old indi-
viduals. Spermidine, an endogenous polyamine
metabolite, induces autophagy in vivo and rejuve-
nates memory B cell responses. Mechanistically,
spermidine post-translationally modifies the transla-
tion factor eIF5A, which is essential for the synthesis
of the autophagy transcription factor TFEB. Spermi-
dine is depleted in the elderly, leading to reduced
TFEB expression and autophagy. Spermidine sup-
plementation restored this pathway and improved
the responses of old human B cells. Taken together,
our results reveal an unexpected autophagy regula-
tory mechanism mediated by eIF5A at the transla-
tional level, which can be harnessed to reverse
immune senescence in humans.
INTRODUCTION
Immune senescence is characterized by the failure of lympho-
cytes to respond adequately to infection, malignancy, and vacci-
nation. During a regular influenza season, about 90% of the
deaths occur in people older than 65 years (Yoshikawa, 2000).
Immune responses to vaccines are known to be particularly inef-
fective in the elderly population (>65 years of age), and yet some
vaccines, such as those for influenza, are given primarily to the
elderly. A major correlate of protection for vaccinations is the
specific antibody titer generated by long-lived plasma B cells.
With a lifespan of several decades, long-lived lymphocytes are
particularly prone to accumulation of intracellular waste.
Autophagy recycles unwanted cytoplasmic material. Auto-
phagy-deficient lymphocytes are unable to generate adequate
responses, in particular long-lived lymphocytes, memory T and
B cells, and plasma B cells (Chen et al., 2014; Pengo et al.,
2013; Puleston et al., 2014; Xu et al., 2014). Reversing immune
aging would also open opportunities to improve management
of age-related morbidities. However, little is known about how
immune senescence can be reversed.
Genetic activation of autophagy extends lifespan in mice (Fer-
na´ndez et al., 2018; Pyo et al., 2013). However, only a few auto-
phagy-inducing drugs reverse aging, one being rapamycin, an
inhibitor of mTOR (Bjedov et al., 2010). Because of the unwanted
effects of mTOR inhibition, there is a need to better understand
mTOR-independent control of autophagy for drug development.
Furthermore, to test anti-aging drugs, blood biomarkers are crit-
ical. As an endogenous polyamine metabolite that declines with
age, spermidine may be key in controlling cellular aging via auto-
phagy (Eisenberg et al., 2009). Previously we found in aged mice
that spermidine improves memory T cell responses (Puleston
et al., 2014), and Eisenberg et al. (2016) showed cardiac function
was restored with spermidine, both in an autophagy-dependent
manner. Herewe investigatedwhether spermidine is able to reju-
venate long-term B cell responses, the main correlate of protec-
tion for vaccination. We found an autophagy-dependent
improvement of B cell responses by spermidine in old mice, indi-
cating an effect across different immune cell types. We further
identified the mechanism by which it regulates autophagy.
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Spermidine post-translationally modifies (hypusinates) eIF5A,
which regulates protein synthesis and autophagy in primary B
cells. Because of the rigid structure of proline, triprolines slow
down translation and require hypusinated eIF5A to form peptide
bonds more effectively (Dever et al., 2014). We find that this is
specifically required for the synthesis of the autophagosomal
and lysosomal master regulator TFEB (Settembre et al., 2011),
which is a short-lived protein containing one triproline motif in
mouse and two in human. Moreover, this pathway is consider-
ably downregulated in immune cells from old individuals, making
its components suitable biomarkers. Importantly, spermidine im-
proves hypusination of eIF5A, TFEB protein expression, auto-
phagic flux, and antibody titers in old human B cells, which has
direct translational relevance.
RESULTS
Six-Week In Vivo Treatment with Spermidine Induces
Autophagy but Does Not Affect Hematopoiesis in
Old Mice
Previously, we demonstrated that autophagic flux is decreased
with age in human and murine T cells (Phadwal et al., 2012; Pu-
leston et al., 2014). Here, we first investigated the extent of the
decrease across bone marrow progenitors and splenic mature
hematopoietic cells, with a method of quantifying endogenous
LC3-II, a marker for autophagosomes, using flow cytometry
that we adapted for primary hematopoietic cells (Cossarizza
et al., 2017). To measure active autophagic flux, we used bafilo-
mycin A1 (BafA1), which is a lysosomal V-ATPase inhibitor that
prevents acidification of lysosomes and their degradative func-
tions, thereby causing accumulation of autophagic substrates,
including LC3-II (Figure 1A). Hematopoietic stem cells (HSCs)
were found to have the highest basal autophagy levels
compared with other hematopoietic cells. Although their auto-
phagic flux was mildly reduced in old mice, it was significantly
decreased in B and T cells from old mice as compared to young
mice (Figure 1A; gating strategy in Figures S1A and S1B). Treat-
ment of mice for 6 weeks with spermidine increased autophagic
flux in most hematopoietic cell types tested (Figure 1A). We then
tested if the in vivo administration of spermidine alleviates typical
hallmarks of hematopoietic aging, including expansion of pheno-
typic HSCs, myeloproliferation, and lymphopenia (Henry et al.,
2011). We observed a significant increase of phenotypic HSCs
and LinSca1+cKit+ cells (LSKs) in old mice, which spermidine
administration did not affect (Figures 1B and S1C). A myeloid-
biased phenotype, including increased myeloid cells and more
significantly diminished mature B and T cells, was found in
spleens of old mice (Figures 1C and S1D). Consistently, multiple
bone marrow myeloid progenitors are expanded (Figures 1D,
S1E, and S1F). Bone marrow pro-B cells (CD43+) also mildly
accumulate (Figures 1E, 1F, S1G, and S1H), in line with the para-
digm that pro-B cell maturation is blocked with age (Klinman and
Kline, 1997). Six weeks of treatment with spermidine does not
affect these aging phenotypes in either spleen or bone marrow
(Figures 1C–1F and S1D–S1H), although longer treatment may
confer a more significant effect, as lifespan extension has previ-
ously been demonstrated with 6 month treatment (Eisenberg
et al., 2016).
Spermidine Restores B Cell Responses in Old Mice
Consistent with the flow cytometry staining of LC3-II (Figure 2A),
reduced autophagic flux was confirmed in old mature B lympho-
cytes by western blot (Figure 2B) and by confocal microscopy
using GFP-LC3 transgenic mice (Figure 2C). Old B lymphocytes
accumulated LC3-II, which did not further increase by BafA1
treatment (Figures 2A–2C). This indicates that autophagic flux
is impaired in old cells at the level of the lysosome.
We then examined whether spermidine improves B cell func-
tion. In mice older than 22 months, the antibody response to im-
munization with the model antigen NP-CGG was markedly
reduced, as expected, and administration of spermidine in drink-
ing water significantly improved IgG1 responses (Figure 2D). In
contrast, Atg7-deleted B cells showed defective memory re-
sponses that mimic the aging phenotype, but spermidine failed
to promote their responses (Figures 2E, S2A, and S2B). How-
ever, it should be noted that this does not exclude alternative
rejuvenationmechanisms of spermidine in addition to autophagy
induction. At the time of sacrifice, we found very small numbers
of long-lived bone marrow NP-specific plasma cells in old mice,
which were significantly restored with spermidine treatment (Fig-
ure 2F). Spermidine did not induce autophagy in B cells or T cells
or improve the antibody responses in young mice (Figures S2C–
S2F). Thus, spermidine restored autophagic flux and the re-
sponses of B lymphocytes in old mice in vivo, and its immune-
boosting effect is lost in autophagy-deficient B cells.
Spermidine Maintains Cellular Autophagy by
Hypusinating eIF5A
We next investigated how spermidine regulates autophagy.
First, we confirmed 100 mM spermidine to be the optimal con-
centration to induce autophagy in the mammalian lymphocytic
Jurkat cell line (Figures S3A and S3B; Eisenberg et al., 2009;
Morselli et al., 2011). Several signaling pathways have been
described downstream of spermidine, including inhibition of his-
tone acetyltransferases (HATs) (Madeo et al., 2018). Therefore,
we assessed whether spermidine inhibits HAT activity and
thereby induces ATG7mRNA expression, as shown in yeast (Ei-
senberg et al., 2009). In none of three approaches (HAT colori-
metric assay, ATG7 qPCR, or acetylated H3 pull-down) did we
find that spermidine had this effect (Figures S3C–S3E). The ace-
tyltransferase p300 has been shown to directly acetylate certain
autophagy proteins, such as ATG7 to inhibit autophagy (Lee and
Finkel, 2009), and spermidine was reported to inhibit p300 activ-
ity (Pietrocola et al., 2015). However, ATG7 acetylation was not
affected by two tested concentrations of spermidine within 6 h
of treatment (Figures S3E and S3F). Spermidine also failed to
affect the activity of AMPK, as assessed using AMPK phosphor-
ylation (Figure S3G). However, we found that spermidine induces
cellular stress (Figure S3H) at the autophagy-inducing dose of
100 mM or higher, demonstrated by increased levels of ATF4
(Figure S3I), phosphorylated eIF2a (Figure S3J), and increased
expression of CHOPmRNA (Figure S3K) in Jurkat cells. Further-
more, high-dose spermidine induced cell death after 24 h (Fig-
ure S3L), presumably because spermidine levels are high in
transformed cell lines, and further uptake is toxic and non-spe-
cifically induces cellular stress responses, likely also inducing
autophagy. Cellular stress was also induced by spermidine in
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Figure 1. Six-Week In Vivo Treatment with Spermidine Induces Autophagy but Does Not Affect Hematopoiesis in Old Mice
(A) The autophagic flux of indicated cell types from young mice (12 weeks), old mice (24 months), and old mice administered spermidine (Spd) for 6 weeks was
measured using LC3-II staining using flow cytometry after 2 h treatment with bafilomycin A1 (BafA1). Representative LC3-II plots of hematopoietic stem cells
(HSCs) and CD4+ T cells are shown (left). Autophagic flux was calculated as LC3-II geometric mean fluorescence intensity: (BafA1-Vehicle)/Vehicle (right). LMPP,
lymphoid-biased multipotent progenitor; MPP, multipotent progenitor. n = 5, 6, and 7 mice for young, old, and old + Spd, respectively.
(B–F) Absolute count of indicated cell types in mice treated as in (A).
(B) Expanded hematopoietic stem and progenitor cells in old mice. LSK, LinSca1+cKit+ cell. n = 6 or 7 mice.
(C) Old mice are lymphopenic (spleen). n = 6–17 mice.
(D) Expanded myeloid progenitors in bone marrow of old mice. GMP, granulocyte-macrophage progenitor; MkP, megakaryocyte progenitor; Pre-GM, pre-
granulocyte/macrophage; Pre-MegE, pre-megakaryocyte/erythrocyte; Pro-Ery, pro-erythroblast cell. n = 6 or 7 mice.
(E) Hardy fractions (A–F) and their correlation with B cell developmental stages. CLP, common lymphoid progenitor; FO, follicular B cell (mature recirculating B
cell); NF, newly formed B cell; Pre-B, precursor B cell; Pro-B, progenitor B cell.
(F) B cell development is mildly blocked at the pro-B cell stage in old mice. n = 7–11 mice.
Data are represented as mean ± SEM. Two-tailed Student’s t test for comparison of young versus old; one-tailed Student’s t test for comparison of old versus
old + Spd (A). Two-tailed Welch’s t test (B–F). *p% 0.05, **p% 0.01, ***p% 0.001, and ****p% 0.0001.
See also Figure S1.
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NIH 3T3 cells as assessed by increased ATF4 expression (Fig-
ure S3M), indicating that high-dose spermidine induces cellular
stress across different cell types.
Therefore, in subsequent experiments, rather than adding
spermidine, we opted for the depletion of spermidine either by
genetic knockdown (KD) of the key spermidine-synthesizing
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Figure 2. Spermidine Restores B Cell Responses in Old Mice
(A) Representative plot of LC3-II staining of B cells (CD19+) from Figure 1A.
(B) Autophagy (LC3-II) of purified B cells from wild-type mice (treated as in Figure 1A) was assessed using western blot. n = 6 or 7 mice.
(C) Old GFP-LC3 transgenic mice were administered spermidine as in Figure 1A. The GFP-LC3 puncta of purified B cells were measured using confocal mi-
croscopy. N = 210–616 cells from four to six mice.
(D) Young or old mice were immunized with NP-CGG and administered spermidine throughout the experiment. Serum NP-specific IgG1 titers were measured
using ELISA. n = 14 (young) or 10 (old/old + spd) mice from two experiments.
(E) B cell-specific Atg7-KO mice (Mb1-Cre, Atg7f/f) were immunized and IgG1 responses assessed as in (D). n = 7 (B-Atg7+/+) or n = 3 (B-Atg7/) mice.
(F) Mice from (D) were culled on day 75, and bone marrow plasma cells secreting NP-specific IgG1 were measured using ELISpot. n = 6–9 mice.
Data are represented as mean ± SEM. Paired one-tailed Student’s t test (B). Mann-Whitney test (C). Welch’s t test (D–F). p values were adjusted using the Holm-
Sidak method for multiple comparisons of the three time points in (D) and (E). *p% 0.05, **p% 0.01, ***p% 0.001, and ****p% 0.0001.
See also Figure S2.
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enzyme, ornithine decarboxylase (ODC), or with the ODC inhib-
itor difluoromethylornithine (DFMO) in NIH 3T3 cells (Figure 3A).
Indeed, genetic KD of Odc with small interfering RNA (siRNA)
(Figure S4A), or DFMO treatment, reduces spermidine levels
substantially, while supplementing cells with spermidine rescues
its levels partially, as measured using gas chromatography-
mass spectrometry (GC-MS) in cell lysates (Figure 3B). This
demonstrates, first, that cultured cells actively synthesize sper-
midine via ODC and, second, that exogenous spermidine is
efficiently taken up to rescue its intracellular levels. Next, we
examined pathways downstream of spermidine that had not
been previously linked to autophagy. In eukaryotic cells, spermi-
dine is a unique substrate for the hypusination of the translation
factor eIF5A (Figure 3A; Rossi et al., 2014). To date, eIF5A is the
only known protein containing the unusual amino acid hypusine
(Dever et al., 2014). Upon KD of Odc in NIH 3T3 cells, or addition
of DFMO, we found reduced LC3-II levels and reduced eIF5A hy-
pusination, while supplementation with spermidine rescued both
(Figures 3C, S4B, and S4C). Similarly, reduced LC3-II levels were
observed when Eif5a was knocked down (Figures 3D and S4D–
S4F).We next depleted the two hypusinating enzymes, deoxyhy-
pusine synthase (DHS) and deoxyhypusine hydroxylase (DOHH),
to study their effects on autophagy. The KD of Dhs and knockout
(KO) of Dohh (P€allmann et al., 2015), or GC7, a specific inhibitor
of DHS, reduced eIF5A hypusination and LC3-II levels (Figures
3E, S4G, and S4H). Although exogenous spermidine restored
LC3-II levels in cells depleted of spermidine, inhibition of eIF5A
hypusination with siDhs or GC7 abrogated this effect (Figures
3F and S4I). Taken together the data indicate that spermidine
maintains cellular basal autophagy by hypusinating eIF5A.
In activated T cells, eIF5A is one of the 20 most abundant pro-
teins (Hukelmann et al., 2016). However, little is known about its
role in lymphocytes. We measured eIF5A levels and autophagy
in primary B cells during activation. LC3-II levels increased sub-
stantially over time upon activation in B cells, as measured using
flow cytometry (Figure 3G) and western blot (Figures 3H and
S4J). This time-dependent increase correlated with increasing
levels of both total and hypusinated eIF5A (Figure 3H). In line
with our data in NIH 3T3 cells, LC3-II levels decreased with
increasing doses of GC7 (Figure 3I). This pathway operates inde-
pendently of mTOR, whose activation inhibits autophagy.
Indeed, GC7 did not activate mTOR, as demonstrated by S6
phosphorylation, a downstream substrate ofmTOR (Figure S4K).
Overall the data indicate that the eIF5A-autophagy pathway is
induced upon activation of primary B cells, and physiological
levels of hypusinated eIF5A are required for efficient autophagy.
eIF5A Hypusination Is Required for TFEB Expression
We next addressed how eIF5A regulates autophagy by identi-
fying changes in expression of proteins involved in the auto-
phagy pathway upon inhibition of eIF5A hypusination. We
performed label-free quantitative mass spectrometry (MS) on
nuclear and cytoplasmic fractions of activated primary B cells
treated with GC7 (Figures 4A and S5A). This was followed by sta-
ble isotope labeling with amino acids in cell culture (SILAC) on
activated primary B cells (Figures 4B and S5B). It has recently
been reported that eIF5A regulates ATG3 protein synthesis in
cell lines (Lubas et al., 2018). However, ATG3 protein levels
were not found reduced in primary B cells treated with GC7, as
shown in our MS results (Figure 4A) and confirmed by western
blot (Figure S5C). Of the autophagy-related proteins detected,
nuclear TFEB was the only one repeatedly found decreased
upon GC7 treatment in both approaches. TFEB is a key tran-
scription factor regulating autophagosomal and lysosomal
biogenesis (Sardiello et al., 2009; Settembre et al., 2011). The ef-
fect of inhibition of eIF5A hypusination by GC7 on overall and nu-
clear TFEBwas confirmed by western blot in activated primary B
cells (Figures 4C and 4D). Accordingly, gene expression of
several TFEB targets was markedly decreased upon GC7 treat-
ment. Genetic KD of Tfeb was sufficient to reduce autophagic
flux in NIH 3T3 cells (Figures 4F and S5D), as reported (Settem-
bre et al., 2011). KD of Eif5a and Dhs, or GC7 treatment in NIH
3T3 cells, led to a decrease in TFEB protein (Figures 4G and
4H). To test if TFEB is affected by spermidine depletion, we in-
hibited spermidine synthesis in NIH 3T3 cells by siOdc or
DFMO. This caused a reduction in TFEB, which was rescued
by exogenous spermidine administration (Figures 4I and S5E),
suggesting that spermidine controls cellular TFEB levels. How-
ever, spermidine failed to maintain TFEB levels when Eif5a was
knocked down or eIF5A hypusination was inhibited (Figures 4J,
S5F, and S5G), indicating that the regulation of TFEB by spermi-
dine is mediated via eIF5A hypusination.
Being a paralog of TFEB, TFE3 has also been reported to pro-
mote autophagy and lysosomal biogenesis (Martina et al., 2014).
Although TFE3 was not detected in either MS experiments (Fig-
ures 4A and 4B), western blots show that TFE3was also reduced
by GC7 treatment in B cells (Figure S5H). However, knocking
down Tfe3 alone did not significantly compromise autophagy
or further reduce autophagy when knocked down together with
siTfeb in NIH 3T3 cells (Figure S5I). Thus we focused on TFEB
hereafter.
Hypusinated eIF5A Regulates TFEB Synthesis
TFEB is a very short-lived protein (<4 h half-life) (Xiao et al., 2015)
compared with other proteins in the cell (median 36 h half-life)
(Cambridge et al., 2011) and is therefore expected to require
more active translation than most proteins. We first investigated
if eIF5A controls overall protein synthesis in lymphocytes, as pre-
viously reported (Landau et al., 2010). We measured translation
by flow cytometry with O-propargyl-puromycin (OPP) and found
that inhibition of eIF5A hypusination by GC7 caused a 30%
reduction in protein synthesis rate in activated primary B cells
(Figure 5A). A similar reduction was observed using a puromy-
cin-independent assay with L-azidohomoalanine (AHA; a methi-
onine analog) incorporation (Figure S5J). To further assess
translational changes caused by GC7, we performed ribosome
profiling in activated primary B cells. Increased ribosome occu-
pancy at the start codon was observed by GC7 treatment (Fig-
ure S5K). However, whether the accumulation of reads at the
start codon is an artifact of cycloheximide treatment during sam-
ple preparation will require further validation. Stalling of ribo-
somes at the triproline-encoding motif (PPP) was found in
activated primary B cells (Figure S5L), as observed in yeast
and bacteria (Doerfel et al., 2013; Schuller et al., 2017; Ude
et al., 2013; Woolstenhulme et al., 2015), indicating that polypro-
line is a conserved ribosome-pausing motif across kingdoms.
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However, GC7 treatment did not further increase the ribosome
occupancy at PPP motifs (Figure S5M). One explanation is that
the no-go decay mechanism of mRNA at the severely stalled re-
gions may lead to loss of reads (Doma and Parker, 2006).
We next investigated whether TFEB synthesis was affected by
GC7 treatment by detecting nascent (recently made) proteins.
By pulling down nascent proteins after 4 h of AHA labeling, a sig-
nificant reduction of nascent TFEB was observed (Figures 5B
and S5N). Interestingly, nascent eIF5A was also mildly reduced,
suggesting an auto-regulatory loop of eIF5A at the translational
level (Figures 5B and S5N). This is not reflected in overall
eIF5A levels, probably because of the short treatment and the
long half-life of eIF5A. Both human and mouse TFEB have at
least one triproline motif (Figure 5C). Indeed, sequences around
this triproline are also ribosome-pausing motifs (SPP and PPV)
(Schuller et al., 2017), suggesting that this triproline-containing
motif may confer TFEB with the specific requirement to rely on
eIF5A for smooth translation. Therefore, we examined if the tri-
proline motif in murine and human TFEB is sufficient to affect
translation rate as regulated by hypusinated eIF5A. We gener-
ated three different constructs, using labile mCherry expression
to report on the synthesis of either the TFEB triproline-containing
motif, 13 consecutive prolines (13Pro), or a random sequence
(Figure 5C). After transfection into NIH 3T3 cells, we measured
translation using the ratio of the reporter mCherry to the transfec-
tion control GFP. As expected, themCherry/GFP ratio wasmildly
reduced byGC7 for the random sequence and reduced by nearly
half for the 13Pro motif, while the synthesis of TFEB triproline
motif was also significantly inhibited (Figure 5D), indicating that
the TFEB triproline motif requires hypusinated eIF5A for efficient
synthesis. Moreover, mutating the triproline motif (PPP to AAA)
partially rescued the expression of TFEB in the absence of hypu-
sinated eIF5A (Figure 5E), indicating that the triproline motif is
one, but not the only mechanism accounting for GC7-induced
TFEB reduction. Overexpression of the triproline-mutated
TFEB induced autophagy to a similar extent as wild-type TFEB
(Figure 5F). However, when the nuclear localization sequence
(NLS) was mutated in addition to triprolines (Roczniak-Ferguson
et al., 2012), autophagy induction was lost. Taken together this
indicates that the polyproline mutation does not compromise
the function of TFEB as a transcription factor. Moreover, overex-
pressing mutant TFEB was sufficient to rescue autophagy in
GC7-treated cells (Figure 5G), indicating that TFEB is critical
for eIF5A-regulated autophagy. These data suggest that hypusi-
nated eIF5A directly facilitates the synthesis of TFEB partially via
the triproline-containing motif. Future studies are required to
reveal other mechanisms of eIF5A-regulated TFEB expression.
Hypusination of eIF5A Is Essential for Hematopoiesis
and B Cell Activation
eIF5A and its hypusination are essential for cellular growth in
cultured cells (Park et al., 1994) and early embryonic develop-
ment in mice (Nishimura et al., 2012), but its tissue-specific func-
tion is still unclear, although inducible whole-body KO of Dhs in
mice leads to a fatal wasting syndrome (P€allmann et al., 2015).
To investigate the function of hypusinated eIF5A during B cell
development and activation in vivo, we generated competitive
mixed bone marrow chimeras with inducible deletion of the hy-
pusinating enzyme DHS. Dhs deletion was induced after long-
term engraftment and B cell lineage reconstitution of CD45.2+
cells was examined on days 8 and 30 after deletion (Figure S6A).
Percentages of CD45.2+ of both transitional and mature circu-
lating B cells in peripheral blood were significantly affected by
Dhs deletion on day 30 (Figures S6B and S6C). Upon sacrifice
of the mice on day 34, we investigated if this was due to a loss
of progenitors in the bone marrow. Unexpectedly, all multipotent
hematopoietic progenitors investigated (HSC, MPP, LMPP, and
LSK) were severely affected by DHS depletion (Figure S6D). This
is in line with a bone marrow hypocellularity reported previously
in whole-body Dhs-KO mice (P€allmann et al., 2015). Consistent
with depleted HSCs, splenic CD45.2+ myeloid cells, which
mostly lack self-renewal capacity and rely on replenishment
from progenitor cells, were also severely depleted after Dhs
deletion (Figure S6E). Similarly, early B cell progenitors (pre-
pro B cells), newly formed B cells and mature B cells from
bone marrow as well as splenic transitional, marginal zone and
follicular B cells were found significantly diminished (Figures
S6F–S6H). The reduced B cell progenitors may result from either
loss of HSCs or intrinsic survival defects. We checked if the re-
maining CD45.2+ cells were indeed deleted forDhs in blood (Fig-
ure S6I), bone marrow, and spleen (Figure S6J). This analysis
revealed that although on day 8 after deletion with tamoxifen,
blood cells were adequately deleted in the floxed Dhs mice, in
cells that survived to day 34, Dhs was not deleted in most
Figure 3. Spermidine Maintains Cellular Autophagy by Hypusinating eIF5A.
(A) Spermidine synthesis and eIF5A hypusination pathway in eukaryotes.
(B) NIH 3T3 cells were transfected with non-targeting control siRNA (siCtrl), siOdc with or without 10 mM spermidine for 3 days, or treated with DFMO for 24 h
where indicated. Cellular spermidine levels were measured using GC-MS. n = 3.
(C) NIH 3T3 cells were treated with DFMO and spermidine as indicated for 24 h. n = 3.
(D) NIH 3T3 cells were transfected with siCtrl or siEif5a-1/2 for 3 days. n = 3. siEif5a-2 was used in all other figures unless specified otherwise.
(E) The KO of Dohh was induced by 4-OHT for indicated days in immortalized transgenic MEFs. n = 3 or 4.
(F) Spermidine-depleted NIH 3T3 cells by siOdc transfection were rescued with spermidine alone or spermidine together with siDhs. LC3-II was measured 3 days
post-transfection. n = 3.
(G and H) Purified murine B cells were cultured with LPS for indicated days. LC3-II and/or eIF5A expression was measured using flow cytometry (G, n = 3 mice)
and western blot (H, n = 7 mice).
(I) B cells were cultured as in (G) for 3 days with indicated concentrations of GC7 added on day 2 for 24 h. n = 6–10 mice.
To measure autophagic flux, cells were treated with 10 nM BafA1 for 2 h before harvesting where indicated. Data represented as mean ± SEM. One-way or two-
way ANOVAwith post hoc Dunnett’s test (D, E, and G, where LC3-II levels under either basal [red bars] or BafA1 [red + blue bars] conditions are compared, H and
I). One-way ANOVA with post hoc Tukey’s test (B, C, and F). *p% 0.05, **p% 0.01, ***p% 0.001, and ****p% 0.0001.
See also Figures S3 and S4.
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mice (Figure S6J). The overall cellularity in bone marrow and
spleen was not affected despite the reduced CD45.2+ cell
numbers (Figure S6K), indicating that the remaining CD45.1+
and non-deleted CD45.2+ cells expanded and filled up the niche.
These data together demonstrate a profound requirement of the
eIF5A pathway in hematopoiesis and long-term survival of
mature B cells.
To circumvent the defects of hematopoiesis and assess the
role of eIF5A hypusination in B cell activation, we further attemp-
ted to delete Dhs after the first immunization with NP-CGG in
Dhs-KO bone marrow chimeric mice supported with Rag1/
bone marrow cells (to provide wild-type hematopoietic cells for
the survival of the mice, without T and B cells). As before, after
3 weeks of deletion, all remaining lymphocytes expressed
wild-type Dhs only. Levels of NP-specific IgG1 post-boost
were not significantly changed in KO mice (data not shown),
which can be attributed to contamination from non-deleted
memory B cells. Overall the data imply that complete inhibition
of eIF5A hypusination kills hematopoietic cells, and its effect
on generation of antibodies cannot easily be investigated in vivo,
because of (1) the rapid elimination of cells knocked out for Dhs
and (2) the limiting deletion efficiency in mature B cells with
inducible deletion models.
To investigate if eIF5A has an effect on B cell activation, we
induced B cell activation ex vivo with LPS while inhibiting hypu-
sination with GC7. The upregulation of early activation markers,
including CD86, CD69, and MHC-II (Figure S6L) was not
changed upon GC7 treatment. However, activation-induced
cell proliferation was severely impaired upon inhibition of hypusi-
nated eIF5A (Figure S6M) in a time-dependent fashion, in line
with the known function of eIF5A in supporting cellular growth
(Park et al., 1994). Taken together, these results indicate that
hypusinated eIF5A is required for signaling events leading to
specific cell fates such as proliferation and persistent antibody
production for which autophagy might be required via its role
in maintenance of organelle homeostasis (Pengo et al., 2013).
Spermidine Induces the Expression of Hypusinated
eIF5A and TFEB in Old Mice
To assess the role of TFEB in murine B cells, we induced the KO
of Tfeb in cultured murine B cells ex vivo (Figures 6A and S6N).
Consistent with the reported functions of TFEB in inducing auto-
phagy in other cell types (Figures 4F, 5F, S5D, and S5I; Settem-
bre et al., 2011), deletion of Tfeb led to reduced autophagic flux
in B cells (Figures 6A and 6B) without reducing cell viability (Fig-
ure S6O). Also, the expression of activation markers CD86 and
MHC II was not compromised (Figures 6C and S6P). Function-
ally, antibody production was significantly reduced by Tfeb KO
as assessed by secreted IgM in culture supernatants (Figure 6D).
Therefore TFEB regulates antibody production of B cells, but the
exact mechanisms require further investigation.
Spermidine levels have been reported to reduce with age in
multiple organs, including mouse spleens (Nishimura et al.,
2006). To assess whether the identified eIF5A-TFEB pathway
is also affected during physiological aging and whether these
changes can be rescued by exogenous spermidine, 2-year-
old mice were treated with spermidine for 6 weeks. Interest-
ingly, not only eIF5A hypusination but also overall eIF5A was
significantly reduced in B cells from old mice (Figure 6E). The
diminished overall eIF5A may partially result from a chronic
decline in hypusination and eIF5A protein synthesis. Notably,
a striking reduction of overall and especially nuclear TFEB
was observed (Figures 6E and 6F), which might be a key cause
of the reduced autophagic flux shown earlier (Figures 2A–2C).
Importantly, spermidine supplementation restored the hypusi-
nation of eIF5A, overall eIF5A expression, and both overall
and nuclear TFEB levels (Figures 6E and 6F). Thus, we observed
an age-related decline of the spermidine-eIF5A-TFEB-auto-
phagy pathway in B cells, which can be improved by spermidine
supplementation. The fact that TFEB expression was
only partially rescued by spermidine (Figures 6E and 6F) sug-
gests the existence of alternative mechanisms regulating
reduced TFEB expression during aging, which requires future
investigation.
Spermidine Induces TFEB Expression and Improves the
Function of Old Human B Cells
To investigate if this pathway regulates aging in human B cells,
we first measured the levels of hypusinated eIF5A and TFEB in
peripheral blood mononuclear cells (PBMCs) from healthy do-
nors of different ages. Consistent with our findings in mice,
PBMCs from donors aged 65 years and older showed a distinct
reduction of TFEB protein. In some aged donors, TFEBwas even
undetectable by western blot (Figure 7A). In contrast, the mRNA
of TFEBwas not reduced in PBMCs from old donors (Figure 7B),
further indicating that the diminished TFEB protein expression in
the elderly is due to post-transcriptional changes. The overall
eIF5A was significantly diminished in human PBMCs from
Figure 4. eIF5A Hypusination Is Required for TFEB Expression
(A) Murine B cells were treated with 10 mM GC7 as in Figure 3I and fractionated for label-free quantitative protein MS analysis. Identified autophagy proteins are
highlighted by enlarged, annotated circles.
(B) Murine B cells were cultured in medium containing amino acids with heavy isotope labeling (GC7 treated) or light isotopes (vehicle). Cells that had divided four
times or more were sorted by flow cytometry and mixed at 1:1 ratio (heavy: light isotope labeling), followed by cell fractionation and protein MS analysis. For the
repeat, the labeling was swapped. Data represent the average of protein changes from the two repeats. Identified autophagy proteins are highlighted as in (A).
(C–E)Murine B cells were treated with GC7 as in (A). The overall TFEB (C) and cytoplasmic/nuclear TFEB (D) were assessed usingwestern blot. (E) The expression
of TFEB-target genes was measured using qPCR with Gapdh as the reference gene. n = 4–8 mice.
(F–I) NIH 3T3 cells were transfectedwith siTfeb (F), siEif5a (G), siDhs (H), or siOdc (I) and treatedwith 10 mMspermidine where indicated (I) for 3 days or treatedwith
100 mMGC7 for 24 h (H). LC3-II (F) or TFEB (G–I) was measured using western blot. n = 3–5. (J) NIH 3T3 cells were transfected with siOdc to deplete endogenous
spermidine and treated with 10 mM spermidine alone or in combination with siDhs transfection. n = 3.
Data are represented asmean ± SEM. Student’s t test (C, D, and F). Two-way ANOVAwith post hoc Sidak’s test (E). One-way ANOVAwith post hoc Dunnett’s test
(G and H) or Tukey’s test (I and J). *p% 0.05, **p% 0.01, ***p% 0.001, and ****p% 0.0001.
See also Figure S5.
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Figure 5. Hypusinated eIF5A Regulates TFEB Synthesis
(A) LPS-stimulated murine splenocytes were treated with GC7 as in Figure 3I or with cycloheximide (CHX) for 2 h. The relative protein synthesis rate of B cells
(B220+CD19+) was measured using OPP-Click assay with flow cytometry. n = 3.
(B) Nascent proteins of GC7-treated murine B cells were labeled with AHA for 4 h, conjugated to biotin by click reaction, and pulled down for western blot.
n = 5 mice.
(C) The polyproline motif of TFEB with its surrounding sequence was inserted before mCherry-degron to report on protein translation. GFP was used to report on
transfection. Thirteen consecutive prolines (13Pro) was used as positive control for translational stalling, while 13 random amino acids (random) was used as
negative control.
(D) NIH 3T3 cells were transfected with the plasmids in (C) for 24 h and treated together with GC7. The expression of GFP and mCherry was measured using flow
cytometry. n = 3.
(legend continued on next page)
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donorsR65 years of age, but the remaining eIF5A was well hy-
pusinated (Figure 7A), suggesting that cells may coordinate the
expression of overall eIF5A with their hypusination levels during
human aging. Indeed, TFEB protein levels correlate well with the
expression of eIF5A (Figure S7A). Using mass spectrometry, we
show that endogenous spermidine in human PBMCs declines
with age (Figure S7B), as reported (Pucciarelli et al., 2012).
Next, we investigated whether TFEB is regulated by spermidine
and eIF5A in human primary B cells. Human B cells from young
donors stimulated with anti-IgM and CD40L and treated with
(E–G) NIH 3T3 cells were transfected with the plasmids expressing wild-type (WT TFEB-HA) (E and F), mutant (Mut TFEB-HA, PPP to AAA) (E–G), or NLS-mutated
(DNLS, RRRR to AAAA) mutant (F) murine TFEB fused with an HA tag at C terminus for 24 h, treated together with GC7 (E and G). The expression of HA-tagged
TFEB (E) and LC3-II (F and G) was assessed using western blot. Irrelevant lanes from the same membrane were removed (F). n = 3–8.
Data are represented as mean ± SEM. Student’s t test (A, B, D, and G), paired t test (E), or one-way ANOVA with post hoc Tukey’s test (F). *p% 0.05, **p% 0.01,
***p% 0.001, and ****p% 0.0001.
See also Figure S5.
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Figure 6. Spermidine Induces the Expression of Hypusinated eIF5A and TFEB in Old Mice
(A–D) Splenic B cells from tamoxifen-inducible Tfeb-KO mice (WT: CAG-Cre/Esr1+, Tfeb+/+; KO: CAG-Cre/Esr1+, Tfebf/f) were cultured with IL4/anti-CD40 and
4-OHT for 4 days. The expression of TFEB, LC3-II, and the activation markers CD86/MHC II were assessed using western blot (A) and flow cytometry (B and C).
The autophagic flux was calculated as in Figure 1A. IgM in culture supernatants was measured using ELISA (D). n = 3 mice.
(E and F) B cells were purified from youngmice (6 weeks), oldmice (24months), or oldmice administered spermidine for 6 weeks. The expression of overall eIF5A,
hypusinated eIF5A, overall TFEB (E), cytoplasmic (C) and nuclear (N) TFEB (F) was assessed using western blot (n = 7 or 8 mice, combined from two independent
experiments).
Data are represented as mean ± SEM. Two-way ANOVA with post hoc Dunnett’s test (A, B, and D). Welch’s t test (E and F). *p% 0.05, **p% 0.01, ***p% 0.001,
and ****p% 0.0001.
See also Figure S6.
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Figure 7. Spermidine Induces TFEB Expression and Improves the Function of Old Human B Cells
(A) The protein levels of TFEB, hypusinated eIF5A, and overall eIF5A of PBMCs from healthy human donors of indicated ages were assessed using western blot. A
representative plot (left) and quantifications (right) are shown. n = 8–15 donors.
(B) TFEB mRNA of human PBMCs was measured using qPCR with GAPDH as the reference gene. n = 7–9 donors.
(C) Sorted B cells from young human donors were cultured with anti-IgM/CD40L and treated with DFMO with or without 10 mM spermidine for 7 days. n = 5
donors.
(D) Sorted B cells from human donors were cultured as in (C) with spermidine and/or GC7 as indicated. The expression of hypusinated (Hyp) or non-hypusinated
(AcLys or Lys) eIF5A was distinguished by two-dimensional western blot of eIF5A. Black arrow, hypusinated Lys50, pH 5.2; red arrow, unmodified Lys50, pH 5.1;
blue arrow, acetylated Lys47 with unmodified Lys50, pH 5.0. The non-hypusination ratio was calculated as eIF5A dot densitometric intensity (AcLys + Lys)/
(AcLys + Lys + Hyp). n = 4 donors.
(E–G) Sorted B cells from old human donors (age 77.5 ± 6.3 years) were cultured as in (C) together with spermidine and GC7. (E) The protein levels of TFEB and
eIF5A hypusination were measured using western blot. (F) Autophagic flux was determined by flow cytometry as in Figure 1A. (G) Supernatant IgG was assessed
using ELISA. n = 4–14 donors.
(legend continued on next page)
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DFMO ex vivo showed reduced eIF5A hypusination and TFEB,
which were rescued by exogenous spermidine supplementation
(Figure 7C).
Last andmost important, we tested if spermidine improves old
human B cell responses. In contrast to non-stimulated naive
PBMCs, ex vivo activated old human B cells showed accumu-
lated non-hypusinated eIF5A, suggesting a defect in hypusina-
tion (Figure 7D). The levels of both eIF5A hypusination and
TFEB (Figures 7D and 7E), as well as autophagic flux (Figure 7F)
were significantly restored by spermidine treatment in B cells
from aged donors in which spermidine levels are naturally low.
IgG production by B cells from aged donors was also improved
(Figure 7G). GC7 treatment abrogated these effects of spermi-
dine (Figures 7D–7G), suggesting that spermidine improves
autophagy and antibody production of old B cells via hypusinat-
ing eIF5A. In contrast, neither the eIF5A-TFEB-autophagy
pathway nor IgG production was increased by spermidine in
young human B cells (Figures S7C–S7E). Thus, replenishment
of spermidine in B cells from aged donors rejuvenated their func-
tion via eIF5A hypusination.
DISCUSSION
This study demonstrates that autophagic flux is regulated trans-
lationally. Although acute autophagy induction may not require
gene expression and protein synthesis, with components being
readily available, long-term autophagic flux does depend on
continued gene expression (Lawrence and Brown, 1993). We
identified one specific mechanism of this regulation, whereby
the polyamine metabolite spermidine is a substrate for the hypu-
sination of the translation factor eIF5A, which in turn controls the
synthesis of TFEB protein. This mechanism operates normally in
the young, in whom spermidine is abundant. In B cells from old
individuals, however, replenishing spermidine levels restored
this pathway, thereby boosting responses in vivo in mice and
ex vivo in humans. Depleted spermidine levels and subsequent
low TFEB expression may be an important cause of the reduc-
tion in autophagy in the aging adaptive immune system, as
well as in other tissues. However, other potential direct or
indirect mechanisms may play a role in the anti-aging effects
of polyamines, such as epigenetic modifications or changes in
metabolism (Puleston et al., 2019).
It was reported that GC7 induces autophagy in the human
fibrosarcoma 2fTGH cell line (Oliverio et al., 2014). The discrep-
ancy between this and our findings may be a result of the high
dose of GC7 (200 mM) used as opposed to 10 mM for primary
B cells and 100 mM for NIH 3T3 cells used here. Treatment
with a high drug dose may induce stress responses and auto-
phagy non-specifically, as demonstrated here for spermidine
(Figures S3H–S3M). In line, the study by Oliverio et al. (2014)
shows that genetic ablation of eIF5A or of its hypusination en-
zymes consistently tends to reduce (not induce) LC3-II expres-
sion in 2fTGH cells.
Coordination of Translation and Autophagy
Translation in lymphocytes is little studied in T cells (Hukelmann
et al., 2016; Tan et al., 2017) and B cells (Diaz-Mun˜oz et al.,
2015). Naive B cells are in a metabolically quiescent state, with
low protein synthesis (low eIF5A expression) and autophagy,
both of which are quickly upregulated after activation. Autophagy
and the translation machinery may then form a regulatory loop to
support the metabolic requirements of proliferation and immuno-
globulin production. In this loop, autophagy provides substrates
and energy for increased translation, while inducing the synthesis
of certain autophagic proteins such as TFEB. Specifically, a
particular requirement for rapid provision of amino acids and
unfoldedprotein degradation byautophagymay exist in long-lived
plasma cells, which secrete antibodies at the rate of about 2,000
molecules per second (Clarke et al., 2015; Pengo et al., 2013).
Translational Control of TFEB
The anti-aging function of TFEB seems to be highly conserved
across species. Earlier studies found it to be an important tran-
scription factor for lifespan extension in C. elegans (Lapierre
et al., 2013). Moreover, it is likely that the control of TFEB via
translation is a broad, maybe universal mechanism, operating
across many tissue types (here in NIH 3T3 cells and in mouse
and human primary B cells). TFEB is known to be post-transla-
tionally controlled via (1) mTORC1-dependent phosphorylation
for cytoplasmic retention, and (2) calcium-dependent dephos-
phorylation to signal for nuclear translocation (Napolitano and
Ballabio, 2016). We now add an mTOR-independent step of
regulation at the level of translation.
ATG3 protein synthesis was recently reported to be controlled
by hypusinated eIF5A in cell lines (Lubas et al., 2018). However,
we could not find a reduction of ATG3 with GC7 treatment in pri-
mary B cells, indicating that it may be cell type specific (Figures
4A and S5C). MHC II also contains polyproline motifs but did not
reduce with GC7 treatment either (Figure S6L). These observa-
tions suggest that the presence of a polyproline motif alone is
insufficient to cause reduced protein expression by inhibition of
hypusinated eIF5A. Indeed, research in bacteria showed that pol-
yproline-induced stalls may lead to reduced protein levels only if
they limit translation more than initiation (Hersch et al., 2014).
Moreover, an auto-regulatory loop exists for the regulation of
Tfeb transcription (Settembre et al., 2013). Therefore, defective
TFEB synthesis may initiate a vicious cycle involving reduced
Tfeb transcription (Figure 4E) and further reduced protein synthe-
sis, eventually leading to overall diminished TFEB protein. Addi-
tionally, we hypothesize that a stronger stalling motif (such as
SPPPVP in TFEB), and TFEB’s short half-life may contribute to
reduced protein expression in the absence of hypusinated
eIF5A,andpredict that other suchproteinsare regulatedbyeIF5A.
Harness the Pathway to Rejuvenate Human Aging
We have shown eIF5A and TFEB levels are correlated with age in
immune cells. Blood aging biomarkers are urgently needed to
Data are represented as mean ± SEM. Unpaired two-tailed Student’s t test (A and D, comparison of young versus old). Welch’s t test (B). Paired one-way ANOVA
with post hoc Tukey’s test (C). Paired one-tailed t test (D, comparisons of old versus old + Spd, old + Spd versus old + Spd + GC7 comparison, E–G). *p% 0.05,
**p% 0.01, ***p% 0.001, and ****p% 0.0001.
See also Figure S7.
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gauge the efficacy of new drugs that prolong health span. Auto-
phagy is one of the few general mechanisms underpinning many
age-related diseases and is therefore a good target for anti-aging
drugs. Last, it has been accepted for decades that hypusination
occursduringor shortly after the synthesis of eIF5A, and themajor-
ity of cellular eIF5A is in its hypusinated form unless artificial treat-
ments are being used to block the hypusination pathway. Herewe
show that under certain physiological conditions, such as aging, a
significant pool of non-hypusinated eIF5A accumulates, probably
because of the lack of spermidine (Figures 6E, 7D, and 7E). This in-
dicates that hypusination of eIF5A can potentially be harnessed
therapeutically for aging or age-related diseases.
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STAR+METHODS
KEY RESOURCES TABLE
REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
GAPDH Merck Millipore MAB374, RRID:AB_2107445
LC3A/B Sigma L8918, RRID:AB_1079382
eIF5A BD Biosciences 611976, RRID:AB_399397
Hypusine Merck Millipore ABS1064, RRID:AB_2631138
Hypusine Creative Biolabs PABL-202
ATG7 Abcam Ab133528, RRID:AB_2532126
ATG3 Abcam Ab108251, RRID:AB_10865145
H3 Cell Signaling 9715, RRID:AB_331563
S6 Cell Signaling 2317, RRID:AB_2238583
pS6 (Ser235/236) Cell Signaling 4858, RRID:AB_916156
AMPKa Cell Signaling 2793, RRID:AB_915794
pAMPKa (T172) Cell Signaling 2535, RRID:AB_331250
AcK Cell Signaling 9441, RRID:AB_331805
ATF4 Santa Cruz sc-200, RRID:AB_2630429
eIF2a Cell Signaling 2103, RRID:AB_836874
p-eIF2a (Ser51) Cell Signaling 9721, RRID:AB_330951
TFEB Bethyl A303-673A, RID:AB_11204751
TFE3 Sigma HPA023881
DHS Abcam Ab190266
b-Actin Cell Signaling 3700, RRID:AB_2242334
CD40 Thermo Fisher 16-0401-86, RRID: AB_468943
IRDye 800CW Donkey Anti-Rabbit IgG (H+L) LI-COR 926-32213, RRID:AB_621848
IRDye 680RD Donkey Anti-Mouse IgG (H+L) LI-COR 926-68022, RRID:AB_10715072
IRDye 800CW Streptavidin LI-COR 926-32230,
Goat anti-Rabbit IgG (H+L) Cross-Adsorbed Secondary
Antibody, Alexa Fluor 568
Thermo Fisher A-11011, RRID: AB_143157
CD16/CD32 Monoclonal Antibody (FcR Block) Thermo Fisher 14-0161-85, RRID:AB_467134
Pacific Blue anti-mouse/human CD44 Antibody BioLegend 103020, RRID:AB_493683
Pacific Blue anti-mouse TER-119/Erythroid Cells Antibody BioLegend 116232, RRID:AB_2251160
Pacific Blue anti-mouse CD45.1 Antibody BioLegend 110722, RRID:AB_492866
Pacific Blue anti-mouse Ly-6G/Ly-6C (Gr-1) Antibody BioLegend 108430, RRID:AB_893556
Pacific Blue anti-mouse Ly-6A/E (Sca-1) Antibody BioLegend 122520, RRID:AB_2143237
Brilliant Violet 605 anti-mouse CD41 Antibody BioLegend 133921, RRID:AB_2563933
Brilliant Violet 605 anti-mouse CD4 Antibody BioLegend 100451, RRID:AB_2564591
Brilliant Violet 605 anti-mouse/human CD45R/B220
Antibody
BioLegend 103244, RRID:AB_2563312
Ly-6A/E (Sca-1) Monoclonal Antibody, PerCP-Cyanine5.5 Thermo Fisher 45-5981-82, RRID:AB_914372
CD19 Monoclonal Antibody, PerCP-Cyanine5.5 Thermo Fisher 45-0193-82, RRID:AB_1106999
FITC anti-mouse Ly-6A/E (Sca-1) Antibody BioLegend 108106, RRID:AB_313343
FITC anti-mouse/human CD45R/B220 Antibody BioLegend 103206, RRID: AB_312991
CD43 Monoclonal Antibody, FITC Thermo Fisher 11-0431-81, RRID:AB_465039
FITC anti-mouse CD4 Antibody BioLegend 100406, RRID:AB_312691
FITC anti-mouse IgM Antibody BioLegend 406506, RRID:AB_315056
(Continued on next page)
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Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
PE anti-mouse/human CD45R/B220 Antibody BioLegend 103208, RRID:AB_312993
PE anti-mouse Ly-51 Antibody BioLegend 108308, RRID:AB_313365
PE anti-mouse/human CD44 Antibody BioLegend 103008, RRID:AB_312959
PE anti-mouse Ly-6G/Ly-6C (Gr-1) Antibody BioLegend 108408, RRID:AB_313373
PE anti-mouse CD135 Antibody BioLegend 135306, RRID:AB_1877217
PE anti-mouse CD19 Antibody BioLegend 115508, RRID:AB_313643
PE anti-mouse/human CD11b Antibody BioLegend 101208, RRID:AB_312791
CD4 Monoclonal Antibody (GK1.5), PE-Cyanine5 Thermo Fisher 15-0041-82, RRID:AB_468695
PE/Cy5 anti-mouse CD5 Antibody BioLegend 100610, RRID:AB_312739
PE/Cy5 anti-mouse CD8a Antibody BioLegend 100710, RRID:AB_312749
PE/Cy5 anti-mouse/human CD11b Antibody BioLegend 101210, RRID:AB_312793
PE/Cy5 anti-mouse CD11c Antibody BioLegend 117316, RRID:AB_493566
PE/Cy5 anti-mouse/human CD45R/B220 Antibody BioLegend 103210, RRID:AB_312995
PE/Cy5 anti-mouse CD3ε Antibody BioLegend 100310, RRID:AB_312675
TCR beta Monoclonal Antibody, PE Thermo Fisher 12-5961-82, RRID:AB_466066
TCR gamma/delta Monoclonal Antibody, PE-Cyanine5 Thermo Fisher 15-5711-82, RRID:AB_468804
PE/Cy5 anti-mouse TER-119/Erythroid Cells Antibody BioLegend 116210, RRID:AB_313711
PE/Cy5 anti-mouse NK-1.1 Antibody BioLegend 108716, RRID:AB_493590
PE/Cy5 anti-mouse Ly-6G/Ly-6C (Gr-1) Antibody BioLegend 108410, RRID:AB_313375
PE/Cy7 anti-mouse CD43 Antibody BioLegend 143210, RRID:AB_2564349
PE/Cy7 anti-mouse CD8a Antibody BioLegend 100722, RRID:AB_312761
PE/Cy7 anti-mouse CD19 Antibody BioLegend 115520, RRID:AB_313655
PE/Cy7 anti-mouse IgM Antibody BioLegend 406514, RRID:AB_10642031
PE/Cy7 anti-mouse CD150 (SLAM) Antibody BioLegend 115914, RRID:AB_439797
APC anti-mouse CD105 Antibody BioLegend 120414, RRID:AB_2277914
APC anti-mouse CD3ε Antibody BioLegend 100312, RRID:AB_312677
TCR beta Monoclonal Antibody, APC Thermo Fisher 17-5961-81, RRID:AB_469480
TCR gamma/delta Monoclonal Antibody, APC Thermo Fisher 17-5711-82, RRID:AB_842756
APC anti-mouse NK-1.1 Antibody BioLegend 108710, RRID:AB_313397
APC anti-mouse/human CD45R/B220 Antibody BioLegend 103212, RRID:AB_312997
APC anti-mouse/human CD11b Antibody BioLegend 101212, RRID:AB_312795
APC anti-mouse Ly-6G/Ly-6C (Gr-1) Antibody BioLegend 108412, RRID:AB_313377
APC anti-mouse CD24 Antibody BioLegend 138506, RRID:AB_2565651
APC anti-mouse CD4 Antibody BioLegend 100412, RRID:AB_312697
APC anti-mouse CD48 Antibody BioLegend 103412, RRID:AB_571997
APC anti-human CD19 BioLegend 302212, RRID:AB_314242
Alexa Fluor 700 anti-mouse CD45.2 Antibody BioLegend 109822, RRID:AB_493731
Alexa Fluor 700 anti-mouse CD8a Antibody BioLegend 100730, RRID:AB_493703
CD8a Monoclonal Antibody, APC-eFluor 780 Thermo Fisher 47-0081-82
APC/Cy7 anti-mouse/human CD11b Antibody BioLegend 101226, RRID:AB_830642
APC/Cy7 anti-mouse IgD Antibody BioLegend 405716, RRID:AB_10662544
APC/Cy7 anti-mouse CD19 Antibody BioLegend 115530, RRID:AB_830707
CD117 (c-Kit) Monoclonal Antibody (2B8), APC-eFluor 780 Thermo Fisher 47-1171-82, RRID:AB_1272177
Goat Anti-Mouse IgG1, Human ads-AP Southern Biotech 1070-04
Rabbit IgG (IP) Santa Cruz sc-2027, RRID:AB_737197
ATG7 (IP) Abcam Ab58735, RRID:AB_940290
AcK (IP) Cell Signaling 9441, RRID:AB_331805
(Continued on next page)
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REAGENT or RESOURCE SOURCE IDENTIFIER
Biological Samples
Healthy adult PBMCs Kennedy Institute of
Rheumatology,
University of Oxford
Rec: 11/h0711/7
UoB Ref: 17-1106
Chemicals
Spermidine Cayman Chemical 14918
Bafilomycin A1 Cayman Chemical 11038
N1-Guanyl-1,7-diaminoheptane (GC7) Merck Millipore 259545-10MG
Difluoromethylornithine (DFMO) Enzo Life Sciences ALX-270-283
Cycloheximide Sigma C1988
4-Hydroxytamoxifen (4-OHT) Sigma H6278
Tamoxifen Sigma T5648
Torin 1 Cayman Chemical 10997
Etoposide Cayman Chemical 12092
NP-CGG (4-Hydroxy-3-nitrophenylacetyl hapten-Chicken
Gamma Globulin)
Biosearch Technologies N-5055D
NP-BSA Biosearch Technologies N-5050H
Critical Commercial Assays
FlowCellectTM Autophagy LC3 Antibody-based
Detection Kit
Merck Millipore FCCH100171
Click-iT Plus OPP Protein Synthesis Assay Thermo Fisher C10456
Click-iT Metabolic Labeling kits Thermo Fisher C10102, C10276
Deposited Data
Ribosome profiling GEO: GSE133934
Mendeley data https://doi.org/10.17632/
cd4f7j2hbh.1
Experimental Models: Cell lines
Jurkat ATCC RRID:CVCL_0367
NIH 3T3 ATCC RRID:CVCL_0594
HEK293T ATCC RRID:CVCL_0063
Experimental Models: Organisms/Strains
Mouse: C57BL/6J The Jackson Laboratory RRID:IMSR_JAX:000664
Mouse: B6.SJL The Jackson Laboratory RRID:IMSR_JAX:100012
Mouse: Mb1-cre The Jackson Laboratory RRID:IMSR_JAX:020505
Mouse: Atg7flox (Komatsu et al., 2005) MGI:3587769
Mouse: GFP-LC3 (Mizushima et al., 2004) MGI:3759813
Mouse: Dhsflox (P€allmann et al., 2015) NA
Mouse: Tcfebflox (Settembre et al., 2012) NA
Mouse: CAG-cre/Esr1 The Jackson Laboratory RRID:IMSR_JAX:004682
Oligonucleotides (siRNA)
Eif5a #1 Dharmacon D-057410-02
Eif5a #2 Dharmacon D-057410-04
Odc #1 Dharmacon D-041731-17
Odc #2 Dharmacon D-041731-03
Dhs #1 Dharmacon D-054953-01
Dhs #2 Dharmacon D-054953-02
Tfeb Dharmacon D-050607-02
Tfe3 Dharmacon L-054750-00
Non-target Dharmacon D-001220-01
(Continued on next page)
e3 Molecular Cell 76, 110–125.e1–e9, October 3, 2019
LEAD CONTACT AND MATERIALS AVAILABILITY
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Anna
Katharina Simon (katja.simon@kennedy.ox.ac.uk).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice
Young (6-12 weeks) and old (22-24 months) C57BL/6J wild-type mice (RRID:IMSR_JAX:000664) were purchased from Charles River
UK. CD45.1+ B6.SJL mice (RRID:IMSR_JAX:100012) were purchased from Charles River UK and bred in BSU at the Kennedy Insti-
tute of Rheumatology.Mb1-cremice were a kind gift from M Reth, Atg7flox mice from M Komatsu (1 year old mice were used in this
study). GFP-LC3 mice from N Mizushima and Stefan Balabanov made the bone marrow from inducible Dhsflox mice available
(P€allmann et al., 2015). Tcfebfloxmice from A Ballabio. CAG-cre/Esr1 mice from the Jackson lab. 5 mM Spermidine (Cayman Chem-
ical) was administered to mice in the drinking water, changed three times per week. All mice were held at Biomedical Services, Uni-
versity of Oxford. Animal experiments were approved by the local ethical review committee and performed under UK project licenses
PPL 30/2809 and then PPL 30/3388.
Cell Lines
Cells (Jurkat, NIH 3T3, HEK293T) were cultured in RPMI-1640 medium supplemented with 10% FBS, Penicillin-Streptomycin (P/S),
and L-Glutamine (all Sigma) in 5% CO2 at 37
C. Stable transduction of the lentivirus to NIH 3T3 cells was performed as previously
described (Preukschas et al., 2012). The IPTG-inducible MISSION shRNA lentiviral vector pLKO-puro-IPTG-3xLacO contains either
the shRNA against the 30-UTR of murine eIF5A mRNA (custom-made from #SHCLND-NM181582-TRCN0000125229, Sigma) or a
corresponding non-target shRNA control (#SHC332-1EA, Sigma). 100 mM IPTG (Thermo Fisher) was used to induce the expression
of shRNA. Immortalized Dohhflox/flox and Dohh+/+ 3T3 cells were established from mouse embryonic fibroblasts (Sievert et al., 2014).
100 nM 4-OHT (H6278, Sigma) freshly prepared in ethanol was used to induce the knockout of Dohh and Tfeb.
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
Recombinant DNA
pMSCV-UBC:GFP Addgene RRID:Addgene_68482
MISSION 3X LacO Inducible Non-Target shRNA Control Sigma SHC332-1EA
TaqMan probes
Gapdh Thermo Fisher Mm99999915_g1
Odc1 Thermo Fisher Mm01964631_g1
Dohh Thermo Fisher Mm00505991_m1
Atg9b Thermo Fisher Mm01157883_g1
Ctsd Thermo Fisher Mm00515586_m1
Gla Thermo Fisher Mm00516323_m1
Neu1 Thermo Fisher Mm00456846_m1
Psap Thermo Fisher Mm00478338_m1
Tfeb Thermo Fisher Mm00448968_m1
Wipi1 Thermo Fisher Mm00461219_m1
GAPDH Thermo Fisher Hs02758991_g1
TFEB Thermo Fisher Hs01115721_m1
ATG7 Thermo Fisher Hs00893770_m1
CHOP Thermo Fisher Hs00358796_g1
Software and Algorithms
FlowJo FlowJo (commercial) https://www.flowjo.com
Prism GraphPad (commercial) https://www.graphpad.com/scientific-
software/prism/
Image Studio Lite LI-COR (commercial) https://www.licor.com/bio/image-studio-lite/?
gclid=Cj0KCQjwpPHoBRC3ARIsALfx-_
JzDOH3Ce3nVzcdgITtx4Xe0ouX62JKl-
h0H5WWVPjdEPnrzl3l08waArTQEALw_wcB
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Human Peripheral Blood
25mL of bloodwas obtained from non-fasting healthy donors (old,R 65 years of age; young,% 65 years of age) in heparinized tubes.
All subjects gave written informed consent. The study was approved by the Ethics Committee of the University of Oxford.
METHOD DETAILS
Bone Marrow Chimera
Bonemarrow cells were collected from the femur and tibia of the donor mice (Dhs+/+ or Dhs/CD45.2+, with young B6.SJL CD45.1+
mice as competitors) and frozen in cryopreservation medium for long-term storage. Carefully thawed cells were counted and mixed
at the indicated ratio for intravenous (iv) injection. The recipient B6.SJL mice were lethally irradiated (550 cGy twice, 4 hours apart)
and rested for 1 hour prior to injection. A total of 1.5 million bone marrow cells were injected intravenously into recipient mice. After at
least 16 weeks of long-term reconstitution, tamoxifen (Sigma) dissolved in corn oil was administered via oral gavage (5 mg/mouse/
day for 5 consecutive days) and peripheral blood and organs were collected for analysis.
Mouse Immunization
Mice were injected intraperitoneally (ip) with 50 mg NP-CGG (N-5055D-5, Biosearch Technologies) precipitated in Imject Alum adju-
vant (Thermo Fisher) on day 0 followed by secondary immunization on or after day 42 (50 mg NP-CGG in PBS ip). Spermidine was
given 2 days before the first immunization and then continuously in drinking water. Peripheral blood samples were collected from
tail vein on indicated days.
Mouse B Cell Purification and Stimulation
Murine splenic B cells were purified using the Pan B Cell Isolation Kit II (130-104-443, Miltenyi). Cells were cultured at a density of
1 million/ml supplemented with 10 mg/ml LPS (Santa Cruz) for stimulation. Medium was replaced on day 3 of culture by replacing
half volume with fresh culture medium containing LPS followed by analysis on day 4 and day 5. For 4-OHT-inducible Tfeb knockout
B cells, cells were stimulated with 10 ng/mL murine recombinant IL-4 (214-14, PeproTech) and 5 mg/mL anti-mouse CD40 antibody
(Thermo Fisher) for 4 days.
Drug Treatments
GC7 (Merck Millipore) was added for 24 hours to B cells (10 mM) on day 2 after B cell stimulation (unless otherwise indicated) or to
Jurkat/NIH 3T3 cells (100 mM). 10 nM bafilomycin A1 (Cayman Chemical), 10 mg/ml cycloheximide (Sigma), or 100 nM Torin 1
(Cayman Chemical) were added to cells for 2 hours. 10 mM etoposide (Cayman Chemical) or 1 mM thapsigargin (Cayman Chemical)
was added to cell culture for 6 hours, or 1 mM difluoromethylornithine (DFMO, Enzo Life Sciences) for 24 hours.
One- and Two-Dimensional Western Blot
For one-dimensional western blot, cells were lysed using NP-40 lysis buffer containing proteinase inhibitors (Sigma) and phospha-
tase inhibitors (Sigma) on ice. After spinning down the debris, protein concentration in the supernatant was quantified by BCA Assay
(23227, Thermo Fisher). Reducing Laemmli Sample Buffer was then added to the supernatant and heated at 100C for 5 minutes.
5-20 mg proteins were loaded for SDS-PAGE analysis. NuPAGE Novex 4%–12% Bis-Tris gradient gel (Thermo Fisher) with MES
running buffer (Thermo Fisher) was used. To improve separation of LC3-I and LC3-II, 15% Tris-HCl gel and SDS running buffer
was used. Proteins were transferred to a PVDF membrane (IPFL00010, Merck Millipore) and blocked with 5% skimmed milk-
TBST. Membranes were incubated with primary antibodies dissolved in 1% milk overnight and secondary antibodies dissolved in
1% milk with 0.01% SDS for imaging using the Odyssey CLx Imaging System. Two-dimensional western blot was carried out as
described before (Preukschas et al., 2012). Data were analyzed using Image Studio Lite or Fiji.
Immunoprecipitation
After treatments an equal number of cells were collected, washed with PBS and lysed using NP-40 lysis buffer with proteinase and
phosphatase inhibitors on ice for 20 minutes. 950 mL lysis buffer was used for 25 million Jurkat cells. Cell debris was centrifuged
down. 50 mL supernatant was collected as whole cell lysate (input control), and the protein concentration was measured by BCA
assay. The remaining supernatant was mixed with 15 mL Protein A Agarose beads (Thermo Fisher) in PBS, then rotated at 4C for
15 minutes to pre-clear the lysate. The beads were removed by centrifugation at 6000 rpm for 1 minute. Immunoprecipitation (IP)
antibody (AcK, ATG7, or rabbit IgG) and 20 mL Protein A agarose beads were added to the lysate and then rotated at 4C overnight.
The beads were washed twice with NP-40 lysis buffer containing proteinase and phosphatase inhibitors and the supernatant dis-
carded. 35 mL 2X Reducing Laemmli Sample Buffer was added to the beads and heated at 100C for 5 minutes, and supernatant
used for western blot analysis.
ELISA
For NP-IgG1 ELISA, ELISA plates (675061, Greiner Bio-One) were coated with 5 mg/ml NP-BSA (N-5050H-10, Biosearch Technol-
ogies) in bicarbonate/carbonate buffer at 4C overnight. After three washes with PBS, plates were blocked with 5% skimmed
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milk in PBS at 37C for 1 hour, followed by 3 x PBSwashes. Serum samples diluted in 1%milk were added and incubated at 37C for
1 hour. For relative quantification, a standard serum sample was made by pooling samples on day 7 post secondary immunization
from a prior experiment, which was used for all subsequent experiments. Serum samples of various days were serially diluted first to
determine the proper dilution, and 1:1000-1:5000 was chosen for NP-IgG1 ELISA. After serum sample incubation, plates were
washed 6 times with PBS-0.05% Tween 20 followed with detection antibody incubation at 37C for 1 hour. Alkaline phosphatase-
(AP-) conjugated goat-anti-mouse IgG1 (Southern Biotech) detection antibody was diluted in 1%milk-PBS at a ratio of 1:2000. After
5 washes with PBS-0.05% Tween 20 and once with PBS, AP-substrate (S0942, Sigma) dissolved in pNPP buffer was added for
15-20 min and absorbance was measured at 405 nm by ELISA plate reader (FLUOstar Omega, BMG Labtech). To detect IgM in cul-
ture supernatants, samples were diluted at the ratio of 1:100. The IgM Mouse Uncoated ELISA Kit (88-50470, Thermo Fisher) was
used according to manufacturer’s protocol.
ELISpot
MultiScreenHTS-HA filter plates (MSHAS4510) were first rinsed with 35% ethanol for 30 s and washed 3 times with PBS. Plates were
coated with 20 mg/ml NP-BSA in PBS at 4C over night. After three washes with PBS, plates were blocked with RPMI-1640 medium
supplemented with 10% FBS at 37C for 30 minutes. Then bone marrow cells were added in duplicates in culture medium at the
density of 3x105 /100 mL/ well and cultured at 37C over night. Plates were then washed 3 times with PBS and 3 times with PBS-
0.05% Tween 20. AP-conjugated anti-mouse IgG1 detection antibody diluted in 1% FBS was added to plates for 1 hour incubation
at 37C. After 5 washes with PBS-0.05% Tween 20 and once with PBS, AP substrate (170-6432, Bio-Rad) was added for spot devel-
opment. Plates with clear spots and clean backgroundwerewashedwith water to stop development, dried, and countedwith the AID
ELISpot Reader System (ELR078IFL, AID GmbH).
Plasmid Construction
The TFEB polyproline motif-mCherry-IRES, 13P-mCherry-IRES, Random-mCherry-IRES, murine wild-type/mutant (PPP to AAA)
Tfeb-HA were cloned into pMSCV-UBC:GFP. A flexible GSGSG linker was inserted between the targeted sequence and mCherry
to assist folding of the fusion protein. The sequence coding C-terminal 37-amino acid degron of murine ODC (Kelly et al., 2007)
was inserted to the C-terminal of mCherry. The nuclear localization sequence RRRR (AGAAGACGCAGG) of TFEB was mutated to
AAAA (GCTGCAGCCGCG) by PCR.
Transfection
NIH 3T3 cells were transfected with siRNA according to Thermo Fisher protocol (13778075, Lipofectamine RNAiMAX Reagent).
Cells were collected on day 3 post-transfection for western blot analysis. For plasmid transfection assay, NIH 3T3 cells were trans-
fected with the indicated plasmids using Lipofectamine 3000 according to the manufacturer’s protocol. Protein expression was
quantified by flow cytometry (geometric mean fluorescence intensity) or western blot 24 hours post transfection.
Flow Cytometry
Cells were stained with fixable Zombie Aqua Live/Dead staining (423102, Biolegend), FcR block, and surface marker antibodies and
analyzed with four-laser LSR Fortessa X-20. Acquired data were analyzed using FlowJo 10.2. For LC3-II flow cytometry staining, the
FlowCellectTM Autophagy LC3 Antibody-based Detection Kit (FCCH100171, Merck Millipore) and for CellTrace staining, CellTrace
Violet (C34557, Thermo Fisher) were used according to the manufacturer’s protocol.
CytoID Staining
Cells were stained with CytoID (ENZ-51031-K200, Enzo Life Sciences) according to manufacturer’s protocol. Briefly, cells were re-
suspended in CytoID staining solution (1:4000 diluted in RPMI without phenol red (R1780, Sigma) supplemented with 5% FBS) and
incubated at 37C for 30 minutes in the dark. Then cells were washed once, followed by surface marker staining and flow cytometry
analysis without fixation.
Quantitative PCR
RNAwas extracted using the RNeasy Plus Mini Kit (74134, QIAGEN). The concentration of RNA wasmeasured using NanoDrop1000
(Thermo Fisher), followed by reverse transcription using the High Capacity RNA-to-cDNA Kit (4387406, Thermo Fisher). Taqman
probes (Thermo Fisher), TaqMan Gene Expression Master Mix (4369016, Thermo Fisher), and the ViiA 7 Real-Time PCR System
(Thermo Fisher) were used for quantitative PCR. DDCt method was used for the quantification of target mRNAs expression using
Gapdh as the reference gene.
Confocal Microscopy
B cells from GFP-LC3 mice were purified by magnetic-activated cell sorting (MACS) and fixed with 4% paraformaldehyde at room
temperature for 10 min. After nuclear staining with DAPI (Sigma), cells were transferred to slides using Cytospin 3 cytocentrifuge
(Shandon) and imagedwith the Olympus FV1200 Laser ScanningMicroscope. CellProfiler software was used for automatic autopha-
gosome quantification. Nuclei were defined in DAPI channel (diameter of 45-100 pixel units), autophagosomes were defined in GFP
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channel (diameter of 3-15 pixel units,1 pixel unit = 100 nm). An artificial but consistent threshold of 1-10 cellular GFP spots in GFP-
LC3 confocal imaging was used for statistical analysis. 10%–45%Bcells are GFP-negative in GFP-LC3 transgenic mice as assessed
by flow cytometry. Therefore cells with 0 GFP spot (either due to no GFP expression or very low autophagy) were excluded from all
samples. Cells with more than 10 GFP spots were also excluded from all samples as outliers.
Cell Fractionation
Cells in a 1.5 mL Eppendorf tube were washed once with cold PBS and re-suspended in 200-500 mL HLB buffer (10 mM Tris-HCl pH
7.5, 10 mM NaCl, 2.5 mM MgCl2) with protease inhibitors and phosphatase inhibitors. Then an equal volume of HLB+2N buffer
(HLB+0.4%NP-40, 1N is 0.2%NP-40) was added and carefully mixed. Samples were incubated on ice for 5minutes and then under-
layed with 200 mL HLB+NS buffer (HLB+0.2%NP-40+10% sucrose). Samples were centrifuged at 500 g for 5 minutes and the upper
half of the supernatant was collected as the cytoplasmic fraction. The remaining liquid was discarded and the nuclear pellet was
washed once more with HLB buffer and lysed with NP-40 lysis buffer or Laemmli sample buffer. All procedures were performed
on ice.
Protein Mass Spectrometry
LPS-stimulatedmouse B cells were treated with 10 mMGC7 on day 2 for 24 hours. Cells were collected and fractionated for label-free
quantitative mass spectrometry (MS) analysis. For SILAC MS, B cells stained with CellTrace Violet (C34557, Thermo Fisher) were
cultured in two types of medium: light and heavy. In light medium, SILAC RPMI-1640 medium (89984, Thermo Fisher) supplemented
with 1.15 mM L-Arg (Sigma) and 0.22 mM L-Lys (Sigma), 10% dialyzed FBS (Sigma), and P/S, L-Glutamine, 50 mM 2-mercaptoetha-
nol, 20 mM HEPES were used. In heavy medium, 13C6
15N4-L-Arg (Arg-10, Silantes) and
13C6
15N2-L-Lys (Lys-8, Silantes) were used
instead of the light arginine and lysine respectively. 10 mMGC7 was added to either light or heavy medium in two repeats. After GC7
treatment, dead cells were first removed using the Dead Cell Removal Kit (Miltenyi). An identical number of cells that had divided at
least 4 times in light or heavy medium were collected by FACS, and mixed for cell fractionation and protein MS analysis.
Peptide samples were prepared using the Filter Aided Sample Preparation (FASP), as previously described (Wisniewski et al.,
2009). Briefly, Vivacon 500 filters (Sartorius, VN01H02 10 kDa/VNCT01) were pre-washed with 200 mL 0.1% trifluoroacetic acid in
50%acetone. Lysate samples were loaded to the filter and denatured with 200 mL 8Murea in 100mM triethylammonium bicarbonate
buffer (TEAB) for 30 minutes at room temperature. Denatured proteins were reduced by 10 mM tris (2-carboxyethyl) phosphine
(TCEP) for 30 minutes at room temperature and alkylated with 50 mM chloroacetamide for 30 minutes at room temperature in the
dark. Subsequently, 1 mg LysC (Wako) in 150 mL 50 mM TEAB containing 6 M urea was added and incubated at 37C for 4 hours.
Then the buffer was diluted to 2 M urea by 50 mM TEAB, followed by adding 0.5 mg trypsin (Promega) overnight at 37C. Trypsinised
samples were centrifuged and the flow-through, containing peptides, was dried and resuspended in 70 mL 10% formic acid (or 5%
formic acid and 5% DMSO for SILAC experiment).
Peptides were separated on an Ultimate 3000 UHPLC system (Thermo Fisher) and electrosprayed directly into a QExactive mass
spectrometer (Thermo Fisher). The peptides were trapped on a C18 PepMap100 pre-column (300 mm i.d. x 5 mm, 100 A˚, Thermo
Fisher) using solvent A (0.1% formic acid in water) at a pressure of 500 bar, then separated on an in-house packed analytical column
(75 mm i.d. packedwith ReproSil-Pur 120C18-AQ, 1.9 mm, 120 A˚, Dr.MaischGmbH) using a linear gradient (length: 120minutes, 15%
to 35% solvent B (0.1% formic acid in acetonitrile), flow rate: 200 nl/min). Data were acquired in a data-dependent mode (DDA). Full
scanMS spectra were acquired in theOrbitrap (scan range 350-1500m/z, resolution 70000, AGC target 3e6, maximum injection time
50 ms). The 10 most intense peaks were selected for HCD fragmentation at 30% of normalized collision energy at resolution 17500,
AGC target 5e4, maximum injection time 120 ms with first fixed mass at 180m/z. Charge exclusion was selected for unassigned and
1+ ions. The dynamic exclusion was set to 20 s.
Raw MS data were processed by MaxQuant (version 1.5.0.35i) for peak detection and quantification (Cox and Mann, 2008; Cox
et al., 2011). MS spectra were searched against theMus musculus UniProt Reference proteome (retrieved 12/01/17) alongside a list
of common contaminants, using the Andromeda search engine with the following search parameters: full tryptic specificity, allowing
two missed cleavage sites, fixed modification was set to carbamidomethyl (C) and the variable modification to acetylation (protein N
terminus) and oxidation (M). The search results were filtered to a false discovery rate (FDR) of 0.01 for proteins, peptides and peptide-
spectrummatches (PSM). Protein intensity distributionswere log2 transformed andmedian-centered using Perseus (version 1.5.5.3).
For the SILAC analysis, missing values were replaced by an estimated background noise value. Proteins without greater-than-back-
ground values in both replicates for at least one condition were removed. MA plots were generated using R (version 3.4.2). Reviewed
autophagy proteins were searched against theMus musculus UniProt database. Data from the independently analyzed cytoplasmic
and nuclear proteins were shown as overlaidMA-plots wherein the log2 average (GC7 + Vehicle) intensity (A) is plotted on x versus the
log2 (GC7:Vehicle) fold change (M) plotted on y.
Spermidine Measurement by Gas Chromatography Mass Spectrometry (GC-MS)
Cells were washed with PBS and the pellet resuspended in lysis buffer (80%methanol + 5% Trifluoroacetic acid) spiked with 2.5 mM
1,7-diaminoheptane (Sigma). The cell suspension, together with acid-washed glass beads (G8772, Sigma), was transferred to a bead
beater tube and homogenized in a bead beater (Precellys 24, Bertin Technologies) for four cycles (6500 Hz, 45 s) with 1 minute of ice
incubation between each cycle. The homogenized samples were centrifuged at 13,000 g for 20 minutes at 4C. The supernatant was
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collected and dried overnight. For chemical derivatization, 200 mL trifluoroacetic anhydride was added to the dried pellet and incu-
bated at 60C for 1 hour, shaking at 1200 rpm. The derivatization product was dried, re-suspended in 30 mL isopropanol and trans-
ferred to glass loading-vials. The samples were analyzed using a GCxGC-MS system as described (Yu et al., 2017). The following
parameters were used for quantification of the 1D-GC-qMS data: type: area, slope: 1000/min, width: 0.04 s, drift 0/min and
T. DBL: 1000 min without any smoothing methods used. Cellular spermidine amount was normalized to total protein levels deter-
mined by BCA assay for each sample first followed by comparison between samples.
OPP-Click Assay
Protein synthesis rate was measured using the Click-iT Plus OPP Protein Synthesis Assay (C10456, Thermo Fisher) according to
manufacturer’s protocol. Geometric mean fluorescence intensity (normalized to vehicle) was used as an indicator of the relative
translation rate.
AHA Labeling of Nascent Proteins
Click-iTMetabolic Labeling kits (C10102, C10276, Thermo Fisher) were used for AHA labeling according to manufacturer’s proto-
col. Briefly, cells were pre-cultured in methionine-free culture media (R7513, Sigma) supplemented with 10% dialyzed FBS, P/S,
L-Cystine, and L-Glutamine for 30 minutes to deplete methionine reserves. 50 mM AHA was then added for 4 hours. Cycloheximide
(10 mg/mL, Sigma) was added 30min before adding AHA to inhibit translation. Cells were lysed in lysis buffer (50mMTris-HCl, pH 8.0,
1% SDS with protease/phosphatase inhibitors). The cleared cell lysate (200 mg protein/sample) was used to perform Click reaction
for biotin labeling. Biotinylated proteins were directly used for western blot to determine the overall protein synthesis rate or pulled
down with streptavidin-agarose beads (50 mL beads/sample, S1638, Sigma) overnight to purify nascent proteins for western blot
analyses.
Ribosome Profiling
The sequencing library was prepared according to the reference (Ingolia, 2010; Ingolia et al., 2013) with the following changes. LPS-
activated B cells were MACS-purified with the Dead Cell Removal Kit (Miltenyi) to remove dead cells prior to cell lysis. 100 mg/ml
cycloheximide was used in the lysis buffer. The B cell lysate was spiked with the S. cerevisiae lysate at the ratio of 13 million B cells:
270 million yeast cells (which equals to 20:4 mg miRNA). Clarified B cell and yeast lysates were RNase I-digested, ribosome purified
and miRNA extracted to determine the miRNA yield for spiking. Size exclusion chromatography (27-5140-01, GE Healthcare) was
used to recover ribosomes. The miRNeasy Micro Kit (QIAGEN) was used to purify miRNAs. Ribosome protected fragments
(RPFs) of 27-30 nt size were purified by gel extraction. The Ribo-Zero Gold rRNA Removal Kits (illumina, MRZG126, MRZY1306)
were used to deplete ribosomal RNAs, in which the Ribo-Zero Removal Solutions from the mouse and yeast kits were mixed at
the ratio of 8 mL: 4 mL to remove both mouse and yeast rRNAs. The following barcoding primers were used for next generation
sequencing. 1. 50-AATGATACGGCGACCACCGAGATCTACACGATCGGAAGAGCACACGTCTGAACTCCAGTCACATGCCATCCG
ACGATCATTGATGG. 2. 50-AATGATACGGCGACCACCGAGATCTACACGATCGGAAGAGCACACGTCTGAACTCCAGTCACTGC
ATCTCCGACGATCATTGATGG. The libraries were sequenced at the Biopolymers Facility, Harvard Medical School.
For the purposes of alignment, the reference genome assemblies for Mus musculus (GRCM38) and Saccharomyces cerevisiae
(SacCer3) were concatenated to create a combined genome fasta file. Prior to alignment, adaptor sequence (ATCTCGTAT
GCCGTCTTCTGCTTG) was removed from demultiplexed reads and low quality reads (Phred score < 20) were discarded. To remove
contaminating rDNA reads, reads were aligned to the combined rDNA genome using bowtie2 and all unaligned reads were kept for
alignment to the combined genome. Non-rDNA reads were aligned to the combined genome using bowtie2. All post-alignment anal-
ysis was performed using custom scripts written in R. P-site offsets for each read-length from 26 to 35 nts in the RPF libraries were
determined by generating metagenes relative to the START codon and applied to aligned reads. For all metagenes, transcripts with
no reads within the window of interest were excluded from analysis before applying any other filters. Additionally, for each position in
the windows of the 50 and 30 metagenes, the highest and lowest 0.1% of signals were removed from analysis.
Human B Cell Assays
Peripheral blood mononuclear cells (PBMCs) were isolated by density gradient centrifugation using Ficoll-Paque. PBMCs were
counted using trypan blue. Theywere either freshly used or frozen until further use. Thawed cells were placed in full medium overnight
to allow selection of viable cells. PBMCs were washed with PBS and lysed using NP-40 lysis buffer containing proteinase inhibitors
and phosphatase inhibitors on ice for western blot assay or using lysis buffer (80% methanol + 5% Trifluoroacetic acid) spiked with
2.5 mM1,7-diaminoheptane (Sigma) for spermidinemeasurement by GC-MS. B cells were sorted using a negative selection kit (B Cell
Isolation Kit II, human, Miltenyi Biotec) according to themanufacturer’s protocol. B cells (53 105 cells) were seeded in 24-well plates,
then activated with anti-IgM (5 mg/ml, Jackson Immuno Research) and CD40L (100 ng/ml, Enzo Life science) and treated with 1 mM
DFMO, 10 mM spermidine, or 10 mMGC7 for 7 days. Cells then were lysed for western blot or stained for LC3-II measurement by flow
cytometry. IgG release in culture supernatants was measured by heterologous two-site sandwich ELISA, according to the manufac-
turer’s protocol (Invitrogen).
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QUANTIFICATION AND STATISTICAL ANALYSIS
Prism software (GraphPad) was used for statistical analyses. Data are represented as mean ± SEM. All data points refer to the mea-
surement of distinct samples (biological repeats). Unpaired two-tailed Student’s t test was used for comparisons between two nor-
mally distributed datasets with equal variances unless specified. One-tailed Student’s t test was used when the null hypothesis has a
clear direction according to current knowledge (e.g., spermidine is an autophagy inducer in multiple systems or Bafilomycin A1 treat-
ment leads to accumulation of LC3-II). Welch’s unequal variances t test was used when the two normally distributed datasets have
unequal variances. Holm-Sidak method was used to adjust P values of a family of multiple t tests with a single null hypothesis. Paired
or unpaired one/two-way ANOVA, followed with post hoc Sidak’s test (comparing two means within each group), Dunnett’s test
(comparing multiple means with the single control within each group), or Tukey’s test (comparing the mean of each sample with
the mean of every other sample), was used for multiple comparisons of normally distributed datasets with one/two variables.
Mann-Whitney U test was used for comparisons between non-parametric datasets. Linear regression with 95% confidence interval
was used to assess the relationships between age and the expression of target proteins or spermidine levels, in which R2was used to
assess the goodness of fit and the P value calculated from F test was used to assess if the slope was significantly non-zero. P value
was used to quantify the statistical significance of the null hypothesis testing. *p% 0.05, **p% 0.01, ***p% 0.001, ****p% 0.0001.
DATA AND CODE AVAILABILITY
Original images are available at https://doi.org/10.17632/cd4f7j2hbh.1
Sequencing results have been deposited to GEO with the accession number GSE133934.
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